AVONEX — Total Revenue
Biogen AVONEX — Total Revenue increased by 0.4% to $163.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.2%, from $166.80M to $163.20M. Over 3 years (FY 2022 to FY 2025), AVONEX — Total Revenue shows a downward trend with a -10.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates sustained market demand or successful pricing strategies, while a decrease often signals competitive pressure from newer therapies or generic entry.
Detailed definition
This metric represents the total gross sales generated from the specific pharmaceutical product line within the company'...
Peer comparison
Comparable to product-specific revenue reporting for mature pharmaceutical assets at peer biotech companies.
biib_segment_avonex_total_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $310.90M | $301.30M | $229.60M | $258.70M | $255.10M | $230.10M | $172.40M | $220.30M | $212.20M | $206.10M | $178.50M | $182.80M | $176.20M | $170.00M | $166.80M | $177.70M | $188.50M | $162.50M | $163.20M |
| QoQ Change | — | -3.1% | -23.8% | +12.7% | -1.4% | -9.8% | -25.1% | +27.8% | -3.7% | -2.9% | -13.4% | +2.4% | -3.6% | -3.5% | -1.9% | +6.5% | +6.1% | -13.8% | +0.4% |
| YoY Change | — | — | — | -16.8% | -15.3% | — | -24.9% | -14.8% | -16.8% | -10.4% | +3.5% | -17.0% | -17.0% | -17.5% | -6.6% | -2.8% | +7.0% | -4.4% | -2.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Biogen's avonex — total revenue?
- Biogen (BIIB) reported avonex — total revenue of $163.20M in Q1 2026.
- How has Biogen's avonex — total revenue changed year-over-year?
- Biogen's avonex — total revenue decreased by 2.2% year-over-year, from $166.80M to $163.20M.
- What is the long-term trend for Biogen's avonex — total revenue?
- Over 3 years (2022 to 2025), Biogen's avonex — total revenue has grown at a -10.6% compound annual growth rate (CAGR), from $973.50M to $695.50M.
- What does avonex — total revenue mean?
- The total amount of money earned from sales of the Avonex product.